NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
4.750
+0.140 (3.04%)
At close: Apr 28, 2026, 4:00 PM EDT
4.780
+0.030 (0.63%)
After-hours: Apr 28, 2026, 4:10 PM EDT
NMTC Revenue
NeuroOne Medical Technologies had revenue of $2.89M in the quarter ending December 31, 2025, a decrease of -11.65%. This brings the company's revenue in the last twelve months to $11.72M, up 103.78% year-over-year. In the fiscal year ending September 30, 2025, NeuroOne Medical Technologies had annual revenue of $12.10M with 250.35% growth.
Revenue (ttm)
$11.72M
Revenue Growth
+103.78%
P/S Ratio
3.42
Revenue / Employee
$650,898
Employees
18
Market Cap
40.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 12.10M | 8.64M | 250.35% |
| Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
| Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
| Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
| Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Nortech Systems | 118.37M |
| Pulmonx | 90.50M |
| TELA Bio | 80.28M |
| Myomo | 40.93M |
| Cytosorbents | 37.06M |
| electroCore | 32.03M |
| Elutia | 12.29M |
NMTC News
- 6 weeks ago - NeuroOne Medical Technologies Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Transcripts
- 6 weeks ago - NeuroOne Medical Technologies Transcript: Investor update - Transcripts
- 2 months ago - NeuroOne Medical Technologies Earnings Call Transcript: Q1 2026 - Transcripts
- 4 months ago - NeuroOne Medical Technologies Earnings Call Transcript: Q4 2025 - Transcripts
- 7 months ago - NeuroOne Medical Technologies Transcript: Investor Update - Transcripts
- 7 months ago - NeuroOne Medical Technologies Transcript: Small-Cap Virtual Conference - Transcripts
- 8 months ago - NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 - GlobeNewsWire
- 9 months ago - NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain - GlobeNewsWire